-
About UsBeijing Northland Biotechnology Co., Ltd. is an innovative biopharmaceutical company specializing in the research, development, production, and sales of gene therapy drugs, recombinant protein drugs, and ophthalmic drugs. -
R&D and ProductsPrimarily dedicated to the research, development, and industrialization of novel bioengineered drugs in areas such as cardiovascular diseases, metabolic disorders, rare diseases, and ophthalmic diseases. -
Investor RelationsGuided by the principle of “Creating Value, Serving Health,” the company is committed to becoming an innovative biopharmaceutical enterprise, contributing to the advancement of China’s pharmaceutical industry and the well-being of humanity.
The NL003 project successfully passed the completion acceptance review for the 2005 Zhongguancun Park Technology Innovation Project.
On March 5, 2008, the completion and acceptance meeting for the Zhongguancun Science Park Technology Innovation Project—Project NL003—was held at the Zhongguancun Biopharmaceutical Park. The project undertaken by the company successfully passed the evaluation conducted by the Assessment Team of the Zhongguancun Science Park Management Committee.
The five evaluation experts attending this acceptance meeting, after thoroughly listening to the project’s final report, unanimously agreed that the project’s technical and quality indicators all met the required standards. Furthermore, they found that the financial management during the implementation period, as well as the allocation and use of funds, were in full compliance with the relevant regulations, and thus approved the project unanimously.
Share to:
Friendly Links: Baidu | NORTHLAND
Contact Information
Address: Room A406, Zhongguancun Biomedical Park, No. 5 Kaituo Road, Shangdi, Haidian District, Beijing
Follow Us
Northland is an innovative biopharmaceutical company specializing in the R&D, manufacturing and sales of gene therapy drugs, recombinant protein drugs and ophthalmic medications.
Web site
NL-BIO
NL003
NL005